drugset / Trial / NCT00003346
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 2
Completed
80 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of acetaminophen plus carmustine in treating patients who have stage III or stage IV melanoma.
Timeline
- Start
- 1997-11
- Primary completion
- 2003-02
- Completion
- 2003-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | — | Oral |
| Subject | carmustine | Small molecule | — | Intravenous |
| Background | Acetylcysteine | Other / unclassified | — | Intravenous |